Embed Size (px)
Citation preview
DY Patil (deemed to be) University School of Medicine,
Nerul, Navi Mumbai [Constituent College of DY Patil (deemed to be) University, established under Sec 3 of UGC
Act 1956]
Pharmacovigilance Unit (Established in 2010)
2020 DY Patil (deemed to be) University School of Medicine, Sector 7, Nerul, Navi Mumbai 400706
Tel: 91-22-27702218 Email id: [email protected]; [email protected]
www.dypatil.edu
Dr DY Patil
Founder President
Dr. Vijay Patil Mrs. Shivani Patil
President Trustee
Contents
Sr. No. Chapter 1 Vision
2 Mission
3 Objectives 4 Members
5 Supporting staff 6 Facility
7 Other resources 8 Activities
9 Research projects and publications related to pharmacovigilance
10 Advisory role of the unit
11 Future activities
Vision
To be recognized as medical institute which provides world-class information related to drug safety and ensures safe use of medicines by a;; healthcare professionals in the institute
Mission
To provide quality information and world-class health care to the society by being compassionate, caring and committed to the service.
Objectives
1. To monitor Adverse Drug Reactions (ADRs) at D Y Patil Hospital and attached healthcare institutions
2. To optimize safe and effective use of medicines at D Y Patil Hospital and attached healthcare institutions
3. To provide the safety related information to all stakeholders
4. To create awareness amongst health care professionals about the importance of ADR reporting
5. To monitor benefit-risk profile of medicines
Members (2019-2020)
Chairman: Dr. Deepak Langade Professor and Head, Department Of Pharmacology Dr. D Y Patil School of Medicine Nerul, Navi Mumbai
993055000
[email protected] [email protected]
Secretary: Dr. Vaishali Thakare Associate Professor Department Of Pharmacology
9869366927
[email protected] [email protected]
Members: Dr. Surekha Patil Dean Dr. D Y Patil School of Medicine, Nerul, Navi Mumbai
9930923108
Dr. Vijaya Badhwar Ex-Dean & Prof., Dept. of Obst. & Gynecology
9820362011 [email protected]
Dr. Rahul Peddawad CEO, Dr. D.Y.Patil Hospital
9892144650 [email protected]
Dr. Anant Patil Asst. Professor Department of Pharmacology
9920449433 [email protected] [email protected]
Dr. Archana Bhate Professor and Head, Department Of General Medicine
9821366812
Dr. N.J.Nadkarni Professor, Department of Dermatology & VD
9820285490
Dr. Meena Kumari Professor, Department of General Surgery
9820319129
Dr. Meena Satia Professor, Department of Obstetrics & Gynecology
9869084018 [email protected]
Dr. Fiona Mahapatro Professor, Department of Psychiatry
9820642258
[email protected] [email protected]
Dr. Rajesh Rai Professor and Head, Department of Pediatrics
9920403863
[email protected] [email protected]
Dr. Prakash Samant Professor and Head, Department of Orthopedics
9821212222
Dr. Shubha Mohite Professor, Department of Anesthesia
9820409985
Dr. Deepali Rajpal Professor, Department of Emergency Medicine
9819180937
Dr. Somnath Mallakmir Professor, Dept. in cardiology
9322282302 [email protected]
Dr. Girija Nair Prof.& Head, Department of Pulmonary medicine
9324294457 [email protected]
Dr. Nita Shanbhag Prof.& Head, Department of Ophthalmology
9322402424 [email protected]
Sheila Ramandiea Head of Nursing services
976946736 [email protected]
Sister Surekha Sister In-charge
8850945321 [email protected]
Supporting staff
Attendant-One
Clerk-One
Facility
The office of “Pharmacovigilance Unit” is located in the Department of
Pharmacology on the fifth floor of the college building.
Other resources
For the effective functioning of the “Pharmacovigilance Unit” following
resources are always available:
Computer: 1
Cupboard: 1
Round the clock internet connection
Books and journals
Books and journals are purchased and kept in central library. These are
available to teaching staff
Hospital is recognised as Adverse Drug Reaction
Monitoring Centre under Pharmacovigilance Program
of India (PvPI).
Activities
The Pharmacovigilance Unit conducts meeting of its members every
quarter
Sensitization program for PG students is done annually
Regular sensitization programs are conducted for nursing professionals
The Pharmacovigilance Unit of the institute receives and submits
Adverse Drug Reactions (ADRs) reported by the healthcare professionals
in the institute
A total of 95 ADRs are reported by different departments in the institute
Distribution of ADRs reported in last 4 years
Other educational activities conducted by the pharmacovigilance unit
S.No Programmes Date Number of attendees
1 Sensitization programme for Post-Graduate students
27/11/2017 70
2 Sensitization of UG students Guest lecture by Dr Deepak Langade
26/11/2018 22,220
3 Sensitization programme for Nursing students
02/11/2018 42
4 Lecture during Medinspire- ADR Reporting: Challenges in Indian healthcare system- Dr. Nitya Gogtey, Additional Professor, Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai
110
5 Lecture during Medinspire- Pharmacovigilance: Reporting systems and mechanisms Dr. Moin Don
14/2/2019 110
6 Lecture during Medinspire- Pharmacovigilance: Global perspective Dr. Sudhir Bansod
14/2/2019 110
5 Sensitization programme for Post graduate students
18/7/2018 95
2
49
41
3
0
10
20
30
40
50
60
Year 2017 Year 2018 Year 2019 Year 2020
Nu
mb
er
of
AD
Rs
6 Sensitization programme for Nursing students
22/6/2019 97
7 Pharmacovigilance workshop Current Global trend in pharmacovigillance & Risk Management- Dr Sudhir Bansode, Senior Director, Pharmavigillance, Switzerland
10/10/2019 43
Invitation letter to Dr. Deepak Langade as Guest Speaker for
conducting Virtual Lecture on “Pharmacovigilance”
Pharmacovigilance sensitization program for nursing staff was conducted on
2/11/2018 at 2.00 PM in Demo room of Male surgical ward. Chairperson of
Pharmacovigilance committee, Dr Deepak Langade, provided introduction on
pharmacovigilance and its Importance to nursing staff of D Y Patil Hospital and
Research Centre, Nerul, Navi Mumbai. Member secretary of Pharmacovigilance
committee, Dr. Vaishali Thakare further elaborated information with power
point presentation. In this program, nurses were also briefed about the
reporting system and importance of accuracy in ADR reporting. Following
members of Pharmacovigilance Committee attended the program. Dr. Archna
Bhate – Prof & Head of General Medicine, Dr. Anant Patil – Assistant Professor
in Pharmacology and Mrs Sheela Remedious – Matron in D.Y. Patil Hospital and
Research Centre.
Conference participation outside institute:
Dr. Anant Patil presented oral paper “Age and gender wise analysis of patients
receiving thalidomide versus overall patient population treated
for Lepra reaction: Retrospective analysis from a tertiary care hospital” in 11th
Annual Conference of South Asian College of Clinical Pharmacology an Affiliate
of Clinical Pharmacology (SAC ACCP), “Clinical Pharmacology: Contributing to
Global Health Policies” (2018)
Dr. Vaishali Thakare and Dr. Kavitha V attended “Advanced
Pharmacovigilance Training Workshop” as a delegate on 5th May 2018
organized by Department of Pharmacology, Seth GS Medical College and
KEM Hospital, Mumbai
Medinspire 2019
Dr. Anant Patil participated as a speaker in 17th Pharmacovigilance 2018 (15th
November) organized by Virtue Insights in Mumbai
Panel discussion: Manual and medical devices reporting: Detecting and evaluating drug safety signals Moderator: S.R.SALUNKHE, Former Assistant commissioner, FDA Maharashtra Panellists: 1. Dr. ARUN BHATT, Consultant – Clinical Research & Development 2. Dr. SANJEEV MIGLANI, Founder and Director, AWINSA Life Sciences 3. JYOTSNA PATWARDHAN, Head Development QA, Novartis 4. Dr. PRADEEPA RAMAKRISHNA, Global Safety Physician/ Lead Surveillance Physician, AstraZeneca 5. Dr. ANANT PATIL, Asst Professor Department of Pharmacology, Dr DY Patil Medical College
Dr. Anant Patil participated as a speaker in 20th Pharmacovigilance 2020 (07th
November 2019) organized by Virtue Insights in Mumbai
Panel discussion: Ensure safe use of medicines and minimizing the risks related to the medicinal product Moderator: PRASHANT BODHE, Director, CliniSearch Panellists: 1. OMPRAKASH S. SADHWANI, Former Joint Commissioner and controlling Authority, Food and Drug Administration (Maharashtra state) 2. Dr. DEEPA ARORA, Director, CLINEXEL Life Sciences
3. Dr. ARUN BHATT, Consultant – Clinical Research & Development 4. Dr. PRADEEPA RAMAKRISHNA, Global Safety Physician/ Lead Surveillance Physician, AstraZeneca 5. Dr. ANANT PATIL, Asst Professor Department of Pharmacology, Dr. DY Patil Medical College 6. Dr. KAVYA KADAM, Consultant Global Clinical Trials
Dr. Anant Patil participated as speaker in 1st Global Pharma
Summit in Mumbai (9th November 2019)
Topic: Pharmacovigilance: How do we do it?
Dr. Vaishali Thakare attended 5 days Skill Development Program on
“Pharmacovigilance for Medical Products” from 23-27th September 2019
organized by National Coordination Centre (NCC), Pharmacovigilance
Program of India (PvPI)
Research projects and Publications
ADR Reporting from Pulmonary Medicine -2018-2019
Dr. Vaishali Thakare and Dr. Deepak Langade from the Department of
Pharmacology and PVPI -Committee, Dr.D.Y. Patil hospital & Research
centre presented paper in CME scheduled on “World TV Day 2019”
Advisory role of the unit
The pharmacovigilance unit provides regular updates on safety signals to
healthcare professionals in the institute which are received from the
PvPI
The pharmacovigilance unit also generates safety signals based on the
adverse drug reactions reported by the healthcare professionals in the
institute and helps in safe use of medicines
Future activities
The pharmacovigilance unit plans to continue efforts of sensitizing the
healthcare professionals and students on importance of adverse drug
reaction reporting and safe use of medicines.
Collaborative activities with other departments
Research projects on pharmacovigilance
Participation in national and international conferences
